FMP
Achieve Life Sciences, Inc.
ACHV
NASDAQ
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
4.61 USD
0.035 (0.759%)
About
ceo
Mr. John A. Bencich M.B.A.
sector
Healthcare
industry
Biotechnology
website
https://www.achievelifesciences.com
exchange
NASDAQ
Description
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
CIK
0000949858
ISIN
US0044685008
CUSIP
004468203
Address
1040 West Georgia Street
Phone
14256861500
Country
CA
Employee
22
IPO Date
Oct 12, 1995
Key Executives
